Bay Street News, 2020

RUTHERFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery […]

 Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal ProductsSOUTH ORANGE, NJ, Aug. 14, 2020 (GLOBE NEWSWIRE) […]

Exebacase Phase 2 study results published in the Journal of Clinical InvestigationContinued patient enrollment in ongoing Phase 3 DISRUPT study […]

Two Additional Orphan Drug Designations Granted for OCU400 Modifier Gene Therapy ProgramConference Call and Webcast Today at 8:30 a.m. ETMALVERN, […]

NEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]

In July 2020, Taat undertook a test production run for Beyond Tobacco™ cigarettes with its manufacturing partner, which confirmed initial […]

VANCOUVER, British Columbia, Aug. 14, 2020 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the […]

FRISCO, TX, Aug. 14, 2020 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (NYSE:CRK) (“Comstock” or the “Company”) announced today that it […]

BOSTON, Aug. 14, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today reported financial results for […]

Initiated Phase 2b clinical trials of IMR-687 in sickle cell disease and beta-thalassemia; First patient dosed in Ardent Phase 2b […]